BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 31010785)

  • 1. Development of a pharmacist-provided contraceptive service following passage of Oregon House Bill 2879.
    Walsh S; Irwin AN; Anderson L; Zehrung C
    J Am Pharm Assoc (2003); 2019; 59(4S):S112-S116. PubMed ID: 31010785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacist prescription and access to hormonal contraception for Medicaid-insured women in Oregon.
    Gibbs SE; Harvey SM
    Contraception; 2020 Oct; 102(4):262-266. PubMed ID: 32652093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time and motion study of pharmacist prescribing of oral hormonal contraceptives in Oregon community pharmacies.
    Frost TP; Klepser DG; Small DC; Doyle IC
    J Am Pharm Assoc (2003); 2019; 59(2):222-227. PubMed ID: 30745187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacist prescription of hormonal contraception in Oregon: Baseline knowledge and interest in provision.
    Rodriguez MI; McConnell KJ; Swartz J; Edelman AB
    J Am Pharm Assoc (2003); 2016; 56(5):521-6. PubMed ID: 27594105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterizing pharmacist-prescribed hormonal contraception services and users in California and Oregon pharmacies.
    Lu S; Rafie S; Hamper J; Strauss R; Kroon L
    Contraception; 2019 Apr; 99(4):239-243. PubMed ID: 30562478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of a pharmacist-led hormonal contraceptive prescribing service in a campus community pharmacy in Indiana, United States.
    Ahmad ZM; Noel NL; Rudd TM; Nadelson CS; Ott MA; Wilkinson TA; Meredith AH
    Contraception; 2022 Sep; 113():113-118. PubMed ID: 35577148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacist Intentions to Prescribe Hormonal Contraception Following New Legislative Authority in California.
    Vu K; Rafie S; Grindlay K; Gutierrez H; Grossman D
    J Pharm Pract; 2019 Feb; 32(1):54-61. PubMed ID: 29096570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An Evaluation of the Implementation of Pharmacist-Prescribed Hormonal Contraceptives in California.
    Batra P; Rafie S; Zhang Z; Singh AV; Bird CE; Sridhar A; Sullivan JG
    Obstet Gynecol; 2018 May; 131(5):850-855. PubMed ID: 29630024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacist prescribing of hormonal contraceptives: results of the Direct Access study.
    Gardner JS; Downing DF; Blough D; Miller L; Le S; Shotorbani S
    J Am Pharm Assoc (2003); 2008; 48(2):212-226. PubMed ID: 18359734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist interest in and attitudes toward direct pharmacy access to hormonal contraception in the United States.
    Landau S; Besinque K; Chung F; Dries-Daffner I; Maderas NM; McGhee BT; Foster DG
    J Am Pharm Assoc (2003); 2009; 49(1):43-50. PubMed ID: 19196596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription of Hormonal Contraception by Pharmacists in Oregon: Implementation of House Bill 2879.
    Rodriguez MI; Anderson L; Edelman AB
    Obstet Gynecol; 2016 Jul; 128(1):168-170. PubMed ID: 27275808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacist Provision of Hormonal Contraception in the Oregon Medicaid Population.
    Anderson L; Hartung DM; Middleton L; Rodriguez MI
    Obstet Gynecol; 2019 Jun; 133(6):1231-1237. PubMed ID: 31135739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergency hormonal contraceptive service provision via community pharmacies in the UK: a systematic review of pharmacists' and young women's views, perspectives and experiences.
    Chirewa B; Wakhisi A
    Perspect Public Health; 2020 Mar; 140(2):108-116. PubMed ID: 31402746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Future of emergency contraception lies in pharmacists' hands.
    Monastersky N; Landau SC
    J Am Pharm Assoc (2003); 2006; 46(1):84-8. PubMed ID: 16529344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implementation of hormonal contraceptive furnishing in San Francisco community pharmacies.
    Chen L; Lim J; Jeong A; Apollonio DE
    J Am Pharm Assoc (2003); 2020; 60(6):963-968.e2. PubMed ID: 32800456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of pharmacist prescription and 12-month contraceptive continuation rates.
    Rodriguez MI; Skye M; Edelman AB; Anderson L; Darney BG
    Am J Obstet Gynecol; 2021 Dec; 225(6):647.e1-647.e9. PubMed ID: 34217725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Encouraging comprehensive and consistent pharmacist education for provision of contraception.
    Anderson L; Borgelt LM; Clark P; Moore G
    J Am Pharm Assoc (2003); 2018; 58(1):113-116. PubMed ID: 29290339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The acceptability of contraception task-sharing among pharmacists in Canada--the ACT-Pharm study.
    Norman WV; Soon JA; Panagiotoglou D; Albert A; Zed PJ
    Contraception; 2015 Jul; 92(1):55-61. PubMed ID: 25818593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of pharmacy access to hormonal contraception.
    Dale LE; Trujillo V; Herman A; Sussman AL; Espey E; Hofler LG
    J Am Pharm Assoc (2003); 2024; 64(1):235-244.e3. PubMed ID: 37890772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community pharmacist-led intervention to identify persons with diabetes not on statin therapy.
    Drake ES; Harris DK; Marciniak MW
    J Am Pharm Assoc (2003); 2018; 58(4S):S125-S130. PubMed ID: 30006183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.